House Health Panel Advances Legislation on PBM’s, Generic Drugs

The Energy and Commerce Health Subcommittee on Wednesday voted to advance a series of healthcare bills, largely on a bipartisan basis. The bills included reforms to the practices of pharmacy benefit managers (PBMs), improving access to generic drugs, and increasing transparency into the prices that hospitals, laboratories, and insurance companies charge. Of particular interest to the life […]

Read More

Teva Launches New “Pivot to Growth” Strategy

Posted on

Return to growth by accelerating a strong innovative medicines portfolio Expand innovative pipeline and focus on core therapeutic areas with first-in-class and best-in-class opportunities Sustain generics powerhouse based on high-value and complex products Focus the business on areas with the greatest potential for growth and patient impact TEL AVIV, Israel–(BUSINESS WIRE)– Teva Pharmaceutical Industries Ltd. […]

Read More

U.S. Patent Office Grants Additional Patent Protection For Exoskeleton Focal-Force Angioplasty Platform

Posted on

Transit Scientific awarded increased U.S. patent protection for their novel exoskeleton focal-force angioplasty technology for use with standard off-the-shelf peripheral transluminal angioplasty (PTA) balloons. Park City, Utah USA, May 18, 2023. Transit Scientific, a Utah-based medical device company, today announced newly issued expanded U.S. patent protection for the XO exoskeleton sheath platform from the United States Patent and Trademark Office […]

Read More

BD Launches World’s First Spectral Cell Sorter with High-Speed Cell Imaging

Posted on

FRANKLIN LAKES, N.J., May 18, 2023 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced the worldwide commercial launch of a new-to-world cell sorting instrument featuring two breakthrough technologies that enable researchers to uncover more detailed information about cells that was previously invisible in traditional flow cytometry experiments. […]

Read More

Michele Baptista Joins CenExel Industry powerhouse brings expertise in early phase clinical trial services to CenExel site network

Posted on

Salt Lake City, Utah — CenExel announces the addition of Michele Baptista as the new Senior Director of Business Development. In this new capacity, Michele will be responsible for developing, selling, and supporting CenExel’s 18-site network for early phase clinical trials, while also identifying new business opportunities and expanding CenExel’s customer base. Michele joins CenExel from WCG IRB, where she […]

Read More

Biomerics Announces Merger with Precision Concepts Medical

Posted on

Biomerics (“Biomerics” or the “Company”), the leading vertically integrated contract manufacturer for the interventional medical device market, announced today that it has entered into definitive agreements to merge with Precision Concepts’ Medical business (“Precision Concepts Medical”). The transaction includes the acquisition of the medical business of Precision Concepts International (“PCI”) as well as Precision Concepts […]

Read More

Sera Prognostics Announces Retirement of President and CEO Dr. Greg Critchfield and Appointment of Board Member Zhenya Lindgardt as Interim CEO

Posted on

SALT LAKE CITY, May 15, 2023 /PRNewswire/ — Sera Prognostics Inc., The Pregnancy Company® (NASDAQ: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomarker information to doctors and patients, today announced the retirement of the Company’s President and CEO, Gregory C. Critchfield, M.D., M.S. Dr. Critchfield is retiring after 12 years […]

Read More

Recursion Appoints David Mauro, M.D., Ph.D., as Chief Medical Officer

Posted on

SALT LAKE CITY, May 16, 2023 (GLOBE NEWSWIRE) — Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today announced it has appointed David Mauro, M.D., Ph.D, as its Chief Medical Officer. Dr. Mauro will lead Recursion’s pipeline into and through clinical development, including its five programs currently in […]

Read More

Nusano and PharmaLogic Announce Collaboration to Enable Next Generation Radiotherapeutics Development

Posted on

SALT LAKE CITY and BOCA RATON, Fla. – May 15, 2023 – Nusano, Inc., a company reshaping the production of cancer-fighting radioisotopes, and PharmaLogic, a world-class contract development and manufacturing organization (CDMO) specializing in radiopharmaceuticals, today announced the two organizations will collaborate to advance the development of radiopharmaceuticals for diagnostic and therapeutic applications.   “PharmaLogic […]

Read More

EY Announces Marcus Gerhardt and Florian Solzbacher of Blackrock Neurotech as Entrepreneur Of The Year® 2023 Mountain West Award Finalists

Posted on

SALT LAKE CITY, May 8, 2023 – Ernst & Young LLP (EY US) today announced that Marcus Gerhardt, co-founder and CEO, and Florian Solzbacher, co-founder and President, of Blackrock Neurotech were named Entrepreneur Of The Year® 2023 Mountain West Award finalists. Now in its 37th year, Entrepreneur Of The Year is one of the preeminent […]

Read More

NUSANO ANNOUNCES IN-HOUSE STABLE ISOTOPE PROGRAM LED BY RENOWNED PHYSICIST SARKO CHEREKDJIAN

Posted on

VALENCIA, Calif. and WEST VALLEY CITY, Utah – May 11, 2023 – Nusano, Inc., a company reshaping the production of cancer-fighting radioisotopes, today announced it is creating an in-house stable isotope program to enhance the company’s medical radioisotope production capabilities and decrease dependence on foreign supply chains. “Enriched, stable isotopes are foundational material for manufacturing […]

Read More

Foldax, Inc. Receives Full Ownership Rights to Proprietary Polymer Patent Portfolio

Posted on

SALT LAKE CITY–(BUSINESS WIRE)–Foldax® Inc. today announced that it has executed an agreement with Australia’s national science agency, CSIRO, for full ownership of a polymer technology patent family. Foldax has incorporated the polymer technology into its LifePolymer™ materials platform and has conducted testing, which indicates the materials are compatible with blood, with low adherence of […]

Read More